News & Perspective

Apr 25, 2007

Apr 25, 2007

HHS offers plan for defense against biological threats

(CIDRAP News) – The US Department of Health and Human Services (HHS) recently unveiled its plan for developing and buying medical countermeasures against a range of biological, chemical, and other threats, with new anthrax and smallpox vaccines among the near-term priorities.

Apr 18, 2007

Apr 18, 2007

Danish firm expects to sell smallpox vaccine to US

(CIDRAP News) – Bavarian Nordic, a Danish company, announced this week that the US government plans to buy 20 million doses of the company's Imvamune smallpox vaccine, but a US official said no decision has been made yet.

Imvamune is Bavarian's version of modified vaccinia Ankara (MVA), which is considered safer than the conventional smallpox vaccine, particularly for people with weakened immune systems, pregnant women, and children.